3059.TW
Altek Corporation [3059.TW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
3059.TW Stock Summary
Top 10 Correlated ETFs
3059.TW
Top 10 Correlated Stocks
3059.TW
In the News
3059.TW Financial details
3059.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 22.6 | 22.29 | 34.2 | 51.31 | 32.9 | |
| Net income per share | -0.01 | 0.59 | 0.85 | 1.67 | 1.27 | |
| Operating cash flow per share | 3.76 | 1.04 | -0.8 | 1.52 | 5.64 | |
| Free cash flow per share | 3.38 | 0.61 | -3.42 | 0.92 | 5.1 | |
| Cash per share | 25.7 | 22.45 | 20.7 | 20.9 | 22.38 | |
| Book value per share | 31.56 | 30.92 | 32.38 | 32.42 | 31.66 | |
| Tangible book value per share | 33.1 | 32.17 | 33.5 | 32.5 | 32.99 | |
| Share holders equity per share | 31.56 | 30.92 | 32.38 | 32.42 | 31.66 | |
| Interest debt per share | 9.36 | 10.08 | 12.25 | 11.95 | 11.63 | |
| Market cap | 6.6B | 9.26B | 12.65B | 9.05B | 10.33B | |
| Enterprise value | 2.47B | 6.62B | 10.5B | 6.91B | 7.8B | |
| P/E ratio | -1.71K | 57.72 | 56.27 | 19.81 | 29.43 | |
| Price to sales ratio | 1.07 | 1.52 | 1.39 | 0.65 | 1.14 | |
| POCF ratio | 6.41 | 32.56 | -59.82 | 21.76 | 6.63 | |
| PFCF ratio | 7.12 | 55.35 | -13.9 | 36 | 7.33 | |
| P/B Ratio | 0.76 | 1.09 | 1.47 | 1.02 | 1.18 | |
| PTB ratio | 0.76 | 1.09 | 1.47 | 1.02 | 1.18 | |
| EV to sales | 0.4 | 1.08 | 1.16 | 0.49 | 0.86 | |
| Enterprise value over EBITDA | 9.03 | 12.31 | 14.06 | 6.23 | 9.9 | |
| EV to operating cash flow | 2.4 | 23.27 | -49.7 | 16.63 | 5 | |
| EV to free cash flow | 2.67 | 39.57 | -11.55 | 27.5 | 5.53 | |
| Earnings yield | 0 | 0.02 | 0.02 | 0.05 | 0.03 | |
| Free cash flow yield | 0.14 | 0.02 | -0.07 | 0.03 | 0.14 | |
| Debt to equity | 0.29 | 0.32 | 0.38 | 0.36 | 0.36 | |
| Debt to assets | 0.18 | 0.19 | 0.2 | 0.2 | 0.2 | |
| Net debt to EBITDA | -15.09 | -4.91 | -2.86 | -1.92 | -3.22 | |
| Current ratio | 2.22 | 1.79 | 1.61 | 1.72 | 2 | |
| Interest coverage | 1.84 | 10.55 | 16.37 | 16.87 | 5.58 | |
| Income quality | 32.78 | 1.18 | -0.53 | 0.62 | 4.44 | |
| Dividend Yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | |
| Payout ratio | -35.56 | 0.87 | 0.6 | 0.42 | 0.79 | |
| Sales general and administrative to revenue | 0.05 | 0.05 | 0.05 | 0.04 | 0 | |
| Research and developement to revenue | 0.13 | 0.17 | 0.15 | 0.12 | 0.15 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | |
| Capex to operating cash flow | -0.1 | -0.41 | 3.3 | -0.4 | -0.1 | |
| Capex to revenue | -0.02 | -0.02 | -0.08 | -0.01 | -0.02 | |
| Capex to depreciation | -0.46 | -0.43 | -2.15 | -0.41 | -0.35 | |
| Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0 | 0 | |
| Graham number | 3.16 | 20.18 | 24.83 | 34.91 | 30.07 | |
| ROIC | 0 | 0.02 | 0.02 | 0.04 | 0.02 | |
| Return on tangible assets | 0 | 0.01 | 0.01 | 0.03 | 0.02 | |
| Graham Net | 12.99 | 7.97 | 4.53 | 6.87 | 6.26 | |
| Working capital | 5.09B | 3.89B | 3.75B | 4.53B | 5.07B | |
| Tangible asset value | 9.06B | 8.81B | 8.9B | 8.88B | 8.96B | |
| Net current asset value | 4.37B | 3.13B | 2.99B | 3.76B | 3.42B | |
| Invested capital | 0.29 | 0.32 | 0.38 | 0.36 | 0.36 | |
| Average receivables | 2.54B | 1.36B | 1.66B | 2.2B | 2.25B | |
| Average payables | 1.44B | 1.15B | 1.63B | 1.8B | 1.44B | |
| Average inventory | 1.02B | 1.07B | 1.9B | 2.55B | 2.09B | |
| Days sales outstanding | 68.4 | 93.75 | 70.15 | 69.28 | 73.81 | |
| Days payables outstanding | 71.28 | 103.3 | 103.93 | 53.62 | 65.57 | |
| Days of inventory on hand | 73.26 | 88.19 | 141.69 | 79.35 | 93.13 | |
| Receivables turnover | 5.34 | 3.89 | 5.2 | 5.27 | 4.95 | |
| Payables turnover | 5.12 | 3.53 | 3.51 | 6.81 | 5.57 | |
| Inventory turnover | 4.98 | 4.14 | 2.58 | 4.6 | 3.92 | |
| ROE | 0 | 0.02 | 0.03 | 0.05 | 0.04 | |
| Capex per share | -0.38 | -0.43 | -2.63 | -0.6 | -0.54 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 11.92 | 8.15 | 7.98 | 8.29 | 8.46 | |
| Net income per share | 0.41 | 0.24 | 0.33 | 0.39 | 0.31 | |
| Operating cash flow per share | 2.54 | 1.98 | 2.39 | -0.04 | 1.31 | |
| Free cash flow per share | 2.53 | 1.95 | 2.25 | -0.12 | 1.03 | |
| Cash per share | 20.71 | 20.78 | 23.31 | 23.72 | 22.37 | |
| Book value per share | 32.13 | 31.29 | 31.12 | 32.55 | 31.65 | |
| Tangible book value per share | 32.2 | 31.41 | 31.14 | 33.63 | 32.97 | |
| Share holders equity per share | 32.13 | 31.29 | 31.12 | 32.55 | 31.65 | |
| Interest debt per share | 11.74 | 12.65 | 12.29 | 11.93 | 11.45 | |
| Market cap | 9.13B | 9.88B | 9.44B | 9.37B | 10.34B | |
| Enterprise value | 7B | 7.89B | 6.76B | 6.49B | 7.8B | |
| P/E ratio | 19.99 | 37.24 | 25.65 | 21.91 | 30.11 | |
| Price to sales ratio | 2.78 | 4.39 | 4.27 | 4.08 | 4.41 | |
| POCF ratio | 13.05 | 18.08 | 14.29 | -834.74 | 28.45 | |
| PFCF ratio | 13.09 | 18.37 | 15.19 | -282.09 | 36.44 | |
| P/B Ratio | 1.03 | 1.14 | 1.1 | 1.04 | 1.18 | |
| PTB ratio | 1.03 | 1.14 | 1.1 | 1.04 | 1.18 | |
| EV to sales | 2.13 | 3.5 | 3.06 | 2.83 | 3.33 | |
| Enterprise value over EBITDA | 25.63 | 37.14 | 26.46 | 22.64 | 29.63 | |
| EV to operating cash flow | 10 | 14.42 | 10.23 | -578.7 | 21.48 | |
| EV to free cash flow | 10.03 | 14.65 | 10.87 | -195.57 | 27.51 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.08 | 0.05 | 0.07 | 0 | 0.03 | |
| Debt to equity | 0.36 | 0.4 | 0.39 | 0.36 | 0.36 | |
| Debt to assets | 0.2 | 0.21 | 0.21 | 0.2 | 0.2 | |
| Net debt to EBITDA | -7.82 | -9.41 | -10.49 | -10.02 | -9.61 | |
| Current ratio | 1.72 | 1.54 | 1.85 | 1.93 | 2 | |
| Interest coverage | 15.48 | 7.43 | 9.93 | 13.29 | 5.01 | |
| Income quality | 3.61 | 5.23 | 4.43 | -0.06 | 4.23 | |
| Dividend Yield | 0.02 | 0 | 0 | 0 | 0.03 | |
| Payout ratio | 1.67 | 0 | 0 | 0 | 3.23 | |
| Sales general and administrative to revenue | 0.06 | 0.06 | 0.06 | 0.07 | 0 | |
| Research and developement to revenue | 0.11 | 0.13 | 0.14 | 0.15 | 0.2 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0 | -0.02 | -0.06 | 1.96 | -0.22 | |
| Capex to revenue | 0 | 0 | -0.02 | -0.01 | -0.03 | |
| Capex to depreciation | -0.03 | -0.09 | -0.43 | -0.26 | -0.43 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 17.3 | 13 | 15.26 | 16.82 | 14.86 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Return on tangible assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Graham Net | 6.81 | 4.03 | 6.14 | 7.44 | 6.25 | |
| Working capital | 4.53B | 3.6B | 4.82B | 5.27B | 5.07B | |
| Tangible asset value | 8.88B | 8.68B | 8.62B | 9.07B | 8.96B | |
| Net current asset value | 3.76B | 2.84B | 3.17B | 3.62B | 3.42B | |
| Invested capital | 0.36 | 0.4 | 0.39 | 0.36 | 0.36 | |
| Average receivables | 2.93B | 2.44B | 2.22B | 2.34B | 2.15B | |
| Average payables | 1.8B | 1.41B | 1.33B | 1.47B | 1.36B | |
| Average inventory | 2.54B | 2.38B | 2.07B | 1.85B | 1.83B | |
| Days sales outstanding | 72.85 | 88.51 | 90.68 | 96.47 | 70.72 | |
| Days payables outstanding | 57.59 | 61.14 | 80.31 | 81.16 | 63.51 | |
| Days of inventory on hand | 85.22 | 119.9 | 98.81 | 104.38 | 90.2 | |
| Receivables turnover | 1.24 | 1.02 | 0.99 | 0.93 | 1.27 | |
| Payables turnover | 1.56 | 1.47 | 1.12 | 1.11 | 1.42 | |
| Inventory turnover | 1.06 | 0.75 | 0.91 | 0.86 | 1 | |
| ROE | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex per share | -0.01 | -0.03 | -0.14 | -0.08 | -0.29 |
3059.TW Frequently Asked Questions
What is Altek Corporation stock symbol ?
Altek Corporation is a TW stock and trading under the symbol 3059.TW
What is Altek Corporation stock quote today ?
Altek Corporation stock price is $38.35 today.
Is Altek Corporation stock public?
Yes, Altek Corporation is a publicly traded company.
Company Profile
- Volume Average 5.7M
- Market Capitalization 11.35B
- Employee 3.21K
- CEO Mr. Ru Win Hsia
- Headquarters Hsinchu City,TW
- IPO Date 2002-12-24
-
Website
https://www.altek.com.tw 
Altek Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of automobile camera, and medical and digital image technology application products. The company provides AI cameras and edge boxes, and PI cameras for home, banking and finance, hotel, retail, and industrial applications; imaging chips for image quality enhancement, face detection, etc.; and 3D sensing modules and solutions for robots, augmented reality/virtual reality devices, surveillance devices, and face payment systems. It offers automobile camera systems, including image assistance system/ mega pixel HD camera, IR camera, AVM, and ADAS for driver monitoring system; and medical imaging solutions, such as glucose meter, intelligent insulin delivery system, and disposable endoscope camera system. In addition, the company offers optical components; manufactures and sells digital still cameras and its accessories; research, development, manufacture, and sale of medical electronic equipment; wholesale, import, and export of digital cameras, digital video cameras, and related accessories; and research, design, and sales of imaging technologies, and electronic software and hardware. It operates in Asia, Europe, the United States, and Taiwan. The company was formerly known as Asia Imagination Corporation and changed its name to Altek Corporation in February 1997. The company was incorporated in 1996 and is headquartered in Hsinchu, Taiwan.
